Abstract
Forty nine renal allograft recipients taking oral cyclosporin suffered 76 episodes of renal dysfunction within six months of transplantation. These episodes were diagnosed as graft rejection or cyclosporin induced nephrotoxicity on the basis of histological findings in allograft biopsy specimens and the response to treatment. Mean predose blood cyclosporin concentrations measured by radioimmunoassay during the week before the onset of renal dysfunction were significantly higher when the cause was cyclosporin toxicity rather than graft rejection (392 v 741 nmol/l (471 v 891 ng/ml). During this period there was a significant association between both the frequency of measurements above 666 nmol/l (800 ng/ml) and the diagnosis of toxicity and the frequency of measurements below 333 nmol/l (400 ng/ml) and the diagnosis of allograft rejection. Cyclosporin measurements made at the time of biopsy and reference to the highest or lowest concentrations measured during the week preceding biopsy were of less value in distinguishing between the two groups. Despite lacking specificity for the parent compound, the radioimmunoassay used produced results which were of clinical value in optimising cyclosporin treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carruthers S. G., Freeman D. J., Koegler J. C., Howson W., Keown P. A., Laupacis A., Stiller C. R. Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay. Clin Chem. 1983 Jan;29(1):180–183. [PubMed] [Google Scholar]
- Donatsch P., Abisch E., Homberger M., Traber R., Trapp M., Voges R. A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay. 1981;2(1):19–32. doi: 10.1080/01971528108062989. [DOI] [PubMed] [Google Scholar]
- Irschik E., Tilg H., Niederwieser D., Gastl G., Huber C., Margreiter R. Cyclosporin blood levels do correlate with clinical complications. Lancet. 1984 Sep 22;2(8404):692–693. doi: 10.1016/s0140-6736(84)91244-3. [DOI] [PubMed] [Google Scholar]
- Johnston A., Marsden J. T., Holt D. W. The United Kingdom Cyclosporin Quality Assessment Scheme. Ther Drug Monit. 1986;8(2):200–204. doi: 10.1097/00007691-198606000-00013. [DOI] [PubMed] [Google Scholar]
- Ptachcinski R. J., Venkataramanan R., Burckart G. J. Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet. 1986 Mar-Apr;11(2):107–132. doi: 10.2165/00003088-198611020-00002. [DOI] [PubMed] [Google Scholar]
- Rogerson M. E., Marsden J. T., Reid K. E., Bewick M., Holt D. W. Cyclosporine blood concentrations in the management of renal transplant recipients. Transplantation. 1986 Feb;41(2):276–278. [PubMed] [Google Scholar]
- Sibley R. K., Rynasiewicz J., Ferguson R. M., Fryd D., Sutherland D. E., Simmons R. L., Najarian J. S. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone. Surgery. 1983 Aug;94(2):225–234. [PubMed] [Google Scholar]
- Taube D. H., Neild G. H., Williams D. G., Cameron J. S., Hartley B., Ogg C. S., Rudge C. J., Welsh K. I. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients. Lancet. 1985 Jul 27;2(8448):171–174. doi: 10.1016/s0140-6736(85)91495-3. [DOI] [PubMed] [Google Scholar]
- Yee G. C., Kennedy M. S., Deeg H. J., Leonard T. M., Thomas E. D., Storb R. Cyclosporine-associated renal dysfunction in marrow transplant recipients. Transplant Proc. 1985 Aug;17(4 Suppl 1):196–201. [PubMed] [Google Scholar]